Research & Development

Multiply Labs' robotic pharmaceutical manufacturing project reaches proof-of-concept

The consortium which contains Multiply Labs, Thermo Fisher, Cytiva, UCSF and Charles River has reached proof-of-concept on a robotic and automated cell manufacturing system

Breaking News

Innovent Biologics and Synaffix expand ADC collaboration

New deal builds on encouraging preliminary clinical data from the Phase I study of the first antibody-drug conjugate (ADC) developed under the agre...

Abzena Partners with ProteoNic to offer enhanced CHO cell line platform for complex biologics

Premium vector technology will improve the production of high-yielding mammalian cell lines

ONK Therapeutics and NAYA Biosciences announce research partnership

ONK Therapeutics and NAYA Biosciences to assess proof-of-concept and establish activity and feasibility of the combination of ONK’s optimally engin...

Getting personal: a patient-centred approach to rare disease drug development

In this article, Nazim Kanji, Executive Director, Pediatric Services at Quotient Sciences, explores the challenges associated with developing formu...

Johnson Matthey partners with Basecamp Research to accelerate the adoption of biocatalysis solutions

Expanding biocatalyst solutions will reduce energy use and waste in pharmaceutical and agrochemical industries

Scientists harness flower “super power” to pave the way for new drug treatments

Researchers at Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells

The roadmap to success in the cannabinoid drug development journey

The key to success in the development and registration of cannabinoid-based medicines hinges on choosing a GMP-certified high-purity active ingredi...

Adding more to the cell and gene therapy playbook

With notable advances in various forms of administration, including making the use of viral vectors safer, non-viral delivery with lipid nanopartic...

Vilnius University research on bacterial defence from viruses published in Science

A team led by Research Professor Gintautas Tamulaitis from Vilnius University Life Sciences Center (VU LSC) revealed a novel protection mechanism i...

NIDA funds studies on PN6047 from PharmNovo for potential opioid withdrawal treatment

The US National Institute of Drug Abuse (NIDA) has funded a project investigating the drug candidate PN6047 from PharmNovo as a potential treatment...

Bio-Courier: a new delivery technology to increase the global accessibility of RNA therapeutics

Although lipid nanoparticles (LNPs) are a key delivery technology for nucleic acid therapeutics, their wider clinical translation is hindered by th...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

Bioxodes closes €12 million in Series A funding round

Funding will enable Bioxodes to continue clinical development of drug candidate for patients with intracerebral hemorrhage

Overcoming cell separation challenges to advance stem cell therapy research

Stem cell therapies are cutting-edge techniques that show promise as highly effective treatments for a wide range of health conditions, including b...

MIMETAS and Yamaha Motor Sign Joint Marketing Agreement Aimed at Advancing Therapeutic Development

Both companies will collaborate to develop innovative applications of the CELL HANDLER in combination with MIMETAS’ 3D tissue models

Revolutionising healthcare through collaboration

The global biomanufacturing industry achieved a valuation of $19.02 billion in 2022, showcasing its significant potential to transform global healt...